Targeting enhanced neutralizing antibody responses via increased germinal center activity: early-phase vaccine trials with novel clinical designs.
- Resource Type
- Article
- Source
- Current Opinion in HIV & AIDS; Nov2023, Vol. 18 Issue 6, p323-330, 8p
- Subject
- Language
- ISSN
- 1746630X